AML can refer to two distinct concepts depending on the context:
1. Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia is a type of cancer that affects the blood and bone marrow. It originates in the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that accumulate in the bone marrow and blood, interfering with normal blood cell production. AML progresses quickly and is typically fatal within weeks or months if untreated. Symptoms include fatigue, shortness of breath, easy bruising or bleeding, and increased risk of infection. It primarily affects adults, especially those over 60, but can occur in younger people as well. Treatment usually involves chemotherapy and may include radiation or stem cell transplantation. AML is one of the most common leukemias in adults and has several subtypes with varying prognoses and treatments
2. Anti-Money Laundering (AML)
Anti-Money Laundering refers to a set of laws, regulations, and procedures designed to prevent criminals from disguising illegally obtained money as legitimate income. These efforts involve financial institutions monitoring and reporting suspicious activities to combat crimes such as tax evasion, drug trafficking, human trafficking, and terrorism financing. AML processes include "Know Your Customer" (KYC) protocols to verify identities and the origins of funds, aiming to stop money laundering at the initial stage. The process of money laundering typically involves placement, layering, and integration of illicit funds. AML regulations have global significance and involve cooperation between governments, financial institutions, and law enforcement agencies
. In summary, AML either refers to a serious blood cancer or to regulatory frameworks aimed at preventing financial crimes, depending on the context.